用户名:
密 码:
注册
|
忘记密码?
首 页
药品信息
药品检索
全部药品
适应症分类
热门药品
专利信息
专利检索
专利权人导航
专利权人分组导航
分类查询
IPC导航
热门检索
专利分析
概况
申请趋势分析
申请人分析
发明人分析
IPC分析
项目文档
项目
个人项目
文档
个人文档
企业文档
公共文档
标签
互动
特色功能
广州科技订制咨询
特色资讯
医药新闻
帮助中心
关于本软件
药品
文档
专利
新闻
所有专利
选择导航
专利权人导航
专利权人分组导航
分类导航
专利权人导航
Aptalis Pharmatech, Inc.(5)
专利信息
Translation Company
查询条件
展开筛选条件
[专利权人] 包含 'Aptalis Pharmatech, Inc.'
[药品] 包含 'Propranolol'
清空条件
查询
分析
排序
公开日
公开号
申请日
申请号
中文标题
英文标题
降序
升序
翻到页码
标题
标题2
专利权人
发明人
附图
摘要
摘要2
优先权号
IPC
专利类型
首页
1
尾页
共
5
条记录, 当前第1/1页。
公开号
公开日
申请号
申请日
1.
US8367111B2
2013/2/5
US10/335295
2002/12/31
专利标题
:Extended release dosage forms of propranolol hydrochloride
专利权人
:
Aptalis Pharmatech, Inc.
;
A unit dosage form such as a capsule or the like for delivering drugs into the body in a sustained release fashion similar to that produced by INDERAL® LA indicated for the treatment of cardiovascular diseases comprises two populations of propranolol-containing particles (beads pellets granules etc.). Each bead population exhibits a pre-designed rapid release profile (i.e. substantially complete release within 60 minutes) or sustained release profile over a period of 24 hours. Such a cardiovascu...
2.
US20060269607A1
2006/11/30
US11/500892
2006/8/9
专利标题
:Timed, sustained release systems for propranolol
专利权人
:
Aptalis Pharmatech, Inc.
;
A unit dosage form such as a capsule or the like for delivering drugs into the body in a circadian release fashion is comprising of one or more populations of propranolol-containing particles (beads pellets granules etc.). Each bead population exhibits a pre-designed rapid or sustained release profile with or without a predetermined lag time of 3 to 5 hours. Such a circadian rhythm release cardiovascular drug delivery system is designed to provide a plasma concentration-time profile which varies...
3.
US20040126427A1
2004/7/1
US10/335295
2002/12/31
专利标题
:Extended release dosage forms of propranolol hydrochloride
专利权人
:
Aptalis Pharmatech, Inc.
;
A unit dosage form such as a capsule or the like for delivering drugs into the body in a sustained release fashion similar to that produced by INDERAL LA indicated for the treatment of cardiovascular diseases comprises two populations of propranolol-containing particles (beads pellets granules etc.). Each bead population exhibits a pre-designed rapid release profile (i.e. substantially complete release within 60 minutes) or sustained release profile over a period of 24 hours. Such a cardiovascul...
4.
US20040047906A1
2004/3/11
US10/453848
2003/6/2
专利标题
:Timed, sustained release systems for propranolol
专利权人
:
Aptalis Pharmatech, Inc.
;
A unit dosage form such as a capsule or the like for delivering drugs into the body in a circadian release fashion is comprising of one or more populations of propranolol-containing particles (beads pellets granules etc.). Each bead population exhibits a pre-designed rapid or sustained release profile with or without a predetermined lag time of 3 to 5 hours. Such a circadian rhythm release cardiovascular drug delivery system is designed to provide a plasma concentrationtime profile which varies ...
5.
US20030157173A1
2003/8/21
US10/334052
2002/12/30
专利标题
:Timed, sustained release systems for propranolol
专利权人
:
Aptalis Pharmatech, Inc.
;
A unit dosage form such as a capsule or the like for delivering drugs into the body in a circadian release fashion is comprising of one or more populations of propranolol-containing particles (beads pellets granules etc.). Each bead population exhibits a pre-designed rapid or sustained release profile with or without a predetermined lag time of 3 to 5 hours. Such a circadian rhythm release cardiovascular drug delivery system is designed to provide a plasma concentrationtime profile which varies ...
首页
1
尾页
共
5
条记录, 当前第1/1页。
当前查询条件: [专利权人] 包含 'Aptalis Pharmatech, Inc.'
AND
[药品] 包含 'Propranolol'
查询范围
在当前结果中查询
!
专利类型
发明
实用新型
外观设计
!
公开号
CN1234
!
申请号
CN1234
!
专利标题
扩展
PHARMA
!
专利权人
扩展
pfizer
发明人
!
申请日
yyyymmdd
!
公开日
yyyymmdd
优先权号
!
摘要
扩展
PHARMA
IPC
A01B
下载范围
下载第
到
条记录。
下载内容
题录信息
专利全文